TTK Healthcare Limited (TTKHLTCARE.NS)
INR 1456.8
(-2.39%)
INR 1456.8
(-2.39%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.68 Billion INR | -28.81% |
| 2022 | 3.77 Billion INR | 22.09% |
| 2021 | 3.09 Billion INR | -18.55% |
| 2020 | 3.79 Billion INR | -0.92% |
| 2019 | 3.82 Billion INR | 5.8% |
| 2018 | 3.61 Billion INR | 8.57% |
| 2017 | 3.33 Billion INR | 16.44% |
| 2016 | 2.86 Billion INR | 0.5% |
| 2015 | 2.84 Billion INR | 8.44% |
| 2014 | 2.62 Billion INR | 19.0% |
| 2013 | 2.2 Billion INR | 14.96% |
| 2012 | 1.92 Billion INR | 17.11% |
| 2011 | 1.63 Billion INR | 11.02% |
| 2010 | 1.47 Billion INR | 25.37% |
| 2009 | 1.17 Billion INR | 17.37% |
| 2008 | 1 Billion INR | 16.74% |
| 2007 | 859.89 Million INR | 7.08% |
| 2006 | 803.02 Million INR | 12.03% |
| 2005 | 716.79 Million INR | 29.99% |
| 2004 | 551.41 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 739.57 Million INR | 20.24% |
| 2024 Q2 | 1.08 Billion INR | -6.82% |
| 2023 Q4 | 615.1 Million INR | -37.41% |
| 2023 Q3 | 982.77 Million INR | -3.78% |
| 2023 FY | 2.68 Billion INR | -28.81% |
| 2023 Q1 | 1.17 Billion INR | 24.96% |
| 2023 Q2 | 1.02 Billion INR | -12.74% |
| 2022 Q2 | 862.92 Million INR | -13.65% |
| 2022 Q4 | 936.75 Million INR | -3.86% |
| 2022 FY | 3.77 Billion INR | 22.09% |
| 2022 Q1 | 999.28 Million INR | 340.74% |
| 2022 Q3 | 974.39 Million INR | 12.92% |
| 2021 Q2 | 1.23 Billion INR | 17.74% |
| 2021 Q1 | 1.04 Billion INR | 2.11% |
| 2021 Q3 | 1.22 Billion INR | -0.21% |
| 2021 FY | 3.09 Billion INR | -18.55% |
| 2021 Q4 | -415.08 Million INR | -133.78% |
| 2020 Q4 | 1.02 Billion INR | -7.01% |
| 2020 Q2 | 986.05 Million INR | 44.39% |
| 2020 FY | 3.79 Billion INR | -0.92% |
| 2020 Q1 | 682.89 Million INR | -13.5% |
| 2020 Q3 | 1.1 Billion INR | 11.68% |
| 2019 Q3 | 1.01 Billion INR | 3.33% |
| 2019 FY | 3.82 Billion INR | 5.8% |
| 2019 Q4 | 789.46 Million INR | -22.32% |
| 2019 Q2 | 983.51 Million INR | -5.47% |
| 2019 Q1 | 1.04 Billion INR | 35.95% |
| 2018 Q4 | 765.27 Million INR | -10.62% |
| 2018 FY | 3.61 Billion INR | 8.57% |
| 2018 Q3 | 856.2 Million INR | -11.97% |
| 2018 Q2 | 972.65 Million INR | -5.15% |
| 2018 Q1 | 1.02 Billion INR | 26.6% |
| 2017 Q3 | 878.21 Million INR | 13.87% |
| 2017 Q4 | 810.01 Million INR | -7.77% |
| 2017 FY | 3.33 Billion INR | 16.44% |
| 2017 Q1 | 667.29 Million INR | 12.97% |
| 2017 Q2 | 771.25 Million INR | 15.58% |
| 2016 Q3 | 667.61 Million INR | -10.53% |
| 2016 Q4 | 590.66 Million INR | -11.53% |
| 2016 Q1 | 853.29 Million INR | 36.88% |
| 2016 Q2 | 746.22 Million INR | -12.55% |
| 2016 FY | 2.86 Billion INR | 0.5% |
| 2015 Q2 | 720.08 Million INR | -5.67% |
| 2015 Q4 | 623.36 Million INR | -15.93% |
| 2015 FY | 2.84 Billion INR | 8.44% |
| 2015 Q1 | 763.37 Million INR | 23.49% |
| 2015 Q3 | 741.5 Million INR | 2.98% |
| 2014 Q1 | 699.18 Million INR | 30.73% |
| 2014 FY | 2.62 Billion INR | 19.0% |
| 2014 Q4 | 618.18 Million INR | -6.02% |
| 2014 Q3 | 657.77 Million INR | 0.96% |
| 2014 Q2 | 651.49 Million INR | -6.82% |
| 2013 Q4 | 534.82 Million INR | -4.44% |
| 2013 FY | 2.2 Billion INR | 14.96% |
| 2013 Q3 | 559.69 Million INR | 5.91% |
| 2013 Q2 | 528.43 Million INR | -9.43% |
| 2013 Q1 | 583.48 Million INR | 24.51% |
| 2012 FY | 1.92 Billion INR | 17.11% |
| 2012 Q2 | 472.6 Million INR | -7.68% |
| 2012 Q1 | 511.9 Million INR | 30.2% |
| 2012 Q4 | 468.62 Million INR | 0.8% |
| 2012 Q3 | 464.91 Million INR | -1.63% |
| 2011 Q4 | 393.17 Million INR | -2.4% |
| 2011 Q3 | 402.82 Million INR | 0.0% |
| 2011 FY | 1.63 Billion INR | 11.02% |
| 2010 FY | 1.47 Billion INR | 25.37% |
| 2009 FY | 1.17 Billion INR | 17.37% |
| 2008 FY | 1 Billion INR | 16.74% |
| 2007 FY | 859.89 Million INR | 7.08% |
| 2006 FY | 803.02 Million INR | 12.03% |
| 2005 FY | 716.79 Million INR | 29.99% |
| 2004 FY | 551.41 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott India Limited | 26.16 Billion INR | 89.733% |
| Cipla Limited | 161.81 Billion INR | 98.34% |
| Gland Pharma Limited | 16.6 Billion INR | 83.818% |
| GlaxoSmithKline Pharmaceuticals Limited | 12.82 Billion INR | 79.045% |
| Kopran Limited | 2.12 Billion INR | -26.33% |
| Marksans Pharma Limited | 7.71 Billion INR | 65.173% |
| NGL Fine-Chem Limited | 1.23 Billion INR | -117.978% |
| Pfizer Limited | 9.9 Billion INR | 72.879% |
| Sanofi India Limited | 16.32 Billion INR | 83.544% |
| SMS Pharmaceuticals Limited | 2.1 Billion INR | -27.358% |